From 2012 to 2022, the Insulin Dosage Market Size Value Per Capita in Canada showed a dynamic pattern. The market size value per capita increased from 31.09 in 2012 to a peak of 38.83 in 2021 before settling at 35.87 in 2022. Notably, there was a significant fluctuation observed during this period, particularly between the years 2012-2015 and 2018-2021. The year-on-year variations indicate considerable volatility, with the most notable decline occurring in 2020 at 28.82 followed by a sharp increase in 2021.
In terms of recent trends, there has been a consistent upward movement over the last two years, with a notable improvement from 2020 to 2022. The Compound Annual Growth Rate (CAGR) over the past five years highlights an average yearly increase, reflecting overall market growth despite yearly fluctuations.
Looking ahead, it will be critical to monitor advancements in insulin delivery technologies, government policies impacting healthcare, and market responses to new diabetes treatment innovations. These factors will likely play pivotal roles in shaping the future trends of this market.
